Non-systemic vasculitic peripheral neuropathy (PN)
Evidence-based neurology checklist on non-systemic vasculitic peripheral neuropathy (pn): Clinical features This accounts for 10% of vasculitic neuropathy The average onset age is 60 years Women account for 60% of cases The features are similar to systemic vasculitis but the prognosis is better…
Clinical features
- This accounts for 10% of vasculitic neuropathy
- The average onset age is 60 years
- Women account for 60% of cases
- The features are similar to systemic vasculitis but the prognosis is better
- Relapses may occur: especially if only steroid treatment was administered
Investigations
First line treatment
Maintenance treatment
Treatment of refractory cases
Treatments of unproven benefit
Monitoring indices
References
- Vrancken AFJE, Hughes RAC, Said G, Wokke JHJ, Notermans NC. Immunosuppressive treatment for non-systemic vasculitic neuropathy. Cochrane Database of Systematic Reviews 2007; Issue 1. Art. No.: CD006050.
- Matthew L, Talbot K, Love S, Puvanarajah S, Donaghy M. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. Q J Med 2007; 100:41-51.
- Collins MP, Dyck JB, Gronseth GS, et al. Peripheral Nerve Society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010; 15:176-184.
